nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.355	0.589	CbGbCtD
Mefenamic acid—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.248	0.411	CbGbCtD
Mefenamic acid—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0398	CcSEcCtD
Mefenamic acid—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0366	CcSEcCtD
Mefenamic acid—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0322	CcSEcCtD
Mefenamic acid—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00875	0.0238	CcSEcCtD
Mefenamic acid—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00857	0.0233	CcSEcCtD
Mefenamic acid—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0083	0.0226	CcSEcCtD
Mefenamic acid—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00776	0.0211	CcSEcCtD
Mefenamic acid—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.0075	0.0204	CcSEcCtD
Mefenamic acid—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00722	0.0196	CcSEcCtD
Mefenamic acid—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00722	0.0196	CcSEcCtD
Mefenamic acid—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00714	0.0194	CcSEcCtD
Mefenamic acid—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00686	0.0187	CcSEcCtD
Mefenamic acid—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00672	0.0183	CcSEcCtD
Mefenamic acid—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00653	0.0178	CcSEcCtD
Mefenamic acid—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00641	0.0174	CcSEcCtD
Mefenamic acid—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00641	0.0174	CcSEcCtD
Mefenamic acid—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00638	0.0174	CcSEcCtD
Mefenamic acid—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.0164	CcSEcCtD
Mefenamic acid—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00595	0.0162	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00593	0.0161	CcSEcCtD
Mefenamic acid—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00508	0.0138	CcSEcCtD
Mefenamic acid—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.0132	CcSEcCtD
Mefenamic acid—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.0126	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.0122	CcSEcCtD
Mefenamic acid—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.0121	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.0119	CcSEcCtD
Mefenamic acid—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00434	0.0118	CcSEcCtD
Mefenamic acid—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.0118	CcSEcCtD
Mefenamic acid—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.0117	CcSEcCtD
Mefenamic acid—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.0117	CcSEcCtD
Mefenamic acid—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0117	CcSEcCtD
Mefenamic acid—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.0115	CcSEcCtD
Mefenamic acid—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.0108	CcSEcCtD
Mefenamic acid—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.0108	CcSEcCtD
Mefenamic acid—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.0108	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.0107	CcSEcCtD
Mefenamic acid—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00389	0.0106	CcSEcCtD
Mefenamic acid—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.0101	CcSEcCtD
Mefenamic acid—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.00964	CcSEcCtD
Mefenamic acid—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.00954	CcSEcCtD
Mefenamic acid—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00946	CcSEcCtD
Mefenamic acid—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00926	CcSEcCtD
Mefenamic acid—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.00922	CcSEcCtD
Mefenamic acid—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.00913	CcSEcCtD
Mefenamic acid—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00886	CcSEcCtD
Mefenamic acid—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.0088	CcSEcCtD
Mefenamic acid—PTGS2—nephron—focal segmental glomerulosclerosis	0.00321	0.264	CbGeAlD
Mefenamic acid—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00872	CcSEcCtD
Mefenamic acid—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00868	CcSEcCtD
Mefenamic acid—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.00859	CcSEcCtD
Mefenamic acid—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00847	CcSEcCtD
Mefenamic acid—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00844	CcSEcCtD
Mefenamic acid—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00841	CcSEcCtD
Mefenamic acid—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00814	CcSEcCtD
Mefenamic acid—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.00811	CcSEcCtD
Mefenamic acid—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00797	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00794	CcSEcCtD
Mefenamic acid—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0029	0.0079	CcSEcCtD
Mefenamic acid—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00782	CcSEcCtD
Mefenamic acid—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00773	CcSEcCtD
Mefenamic acid—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00767	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00767	CcSEcCtD
Mefenamic acid—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.00762	CcSEcCtD
Mefenamic acid—Fenoprofen—ALB—focal segmental glomerulosclerosis	0.0028	0.219	CrCbGaD
Mefenamic acid—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00751	CcSEcCtD
Mefenamic acid—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00745	CcSEcCtD
Mefenamic acid—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00731	CcSEcCtD
Mefenamic acid—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00694	CcSEcCtD
Mefenamic acid—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00689	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—ALB—focal segmental glomerulosclerosis	0.00253	0.198	CrCbGaD
Mefenamic acid—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00684	CcSEcCtD
Mefenamic acid—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00682	CcSEcCtD
Mefenamic acid—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.00675	CcSEcCtD
Mefenamic acid—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00667	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00662	CcSEcCtD
Mefenamic acid—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00656	CcSEcCtD
Mefenamic acid—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00632	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00627	CcSEcCtD
Mefenamic acid—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00609	CcSEcCtD
Mefenamic acid—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00606	CcSEcCtD
Mefenamic acid—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00606	CcSEcCtD
Mefenamic acid—Salicylic acid—ALB—focal segmental glomerulosclerosis	0.00208	0.163	CrCbGaD
Mefenamic acid—AKR1C3—nephron tubule—focal segmental glomerulosclerosis	0.00205	0.169	CbGeAlD
Mefenamic acid—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.0055	CcSEcCtD
Mefenamic acid—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00543	CcSEcCtD
Mefenamic acid—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00525	CcSEcCtD
Mefenamic acid—Diclofenac—ALB—focal segmental glomerulosclerosis	0.00186	0.146	CrCbGaD
Mefenamic acid—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00507	CcSEcCtD
Mefenamic acid—Flurbiprofen—ALB—focal segmental glomerulosclerosis	0.00183	0.143	CrCbGaD
Mefenamic acid—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00488	CcSEcCtD
Mefenamic acid—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00484	CcSEcCtD
Mefenamic acid—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00483	CcSEcCtD
Mefenamic acid—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0048	CcSEcCtD
Mefenamic acid—AKR1C3—cortex of kidney—focal segmental glomerulosclerosis	0.00175	0.144	CbGeAlD
Mefenamic acid—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00456	CcSEcCtD
Mefenamic acid—Ketoprofen—ALB—focal segmental glomerulosclerosis	0.00165	0.129	CrCbGaD
Mefenamic acid—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00158	0.13	CbGeAlD
Mefenamic acid—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00151	0.125	CbGeAlD
Mefenamic acid—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000786	0.0647	CbGeAlD
Mefenamic acid—PTGS1—kidney—focal segmental glomerulosclerosis	0.000637	0.0525	CbGeAlD
Mefenamic acid—PTGS2—kidney—focal segmental glomerulosclerosis	0.000609	0.0502	CbGeAlD
Mefenamic acid—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.000353	0.0826	CbGpPWpGaD
Mefenamic acid—PTGS2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00028	0.0656	CbGpPWpGaD
Mefenamic acid—AKR1C1—Retinoid metabolism and transport—LPL—focal segmental glomerulosclerosis	0.000255	0.0596	CbGpPWpGaD
Mefenamic acid—AKR1C2—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000253	0.0591	CbGpPWpGaD
Mefenamic acid—AKR1C1—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000186	0.0434	CbGpPWpGaD
Mefenamic acid—AKR1C3—Retinoid metabolism and transport—LPL—focal segmental glomerulosclerosis	0.000171	0.0401	CbGpPWpGaD
Mefenamic acid—AKR1C1—Diseases associated with visual transduction—LPL—focal segmental glomerulosclerosis	0.00013	0.0304	CbGpPWpGaD
Mefenamic acid—AKR1C3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000125	0.0292	CbGpPWpGaD
Mefenamic acid—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000109	0.0255	CbGpPWpGaD
Mefenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	9.87e-05	0.0231	CbGpPWpGaD
Mefenamic acid—AKR1C3—Diseases associated with visual transduction—LPL—focal segmental glomerulosclerosis	8.75e-05	0.0205	CbGpPWpGaD
Mefenamic acid—PTGS2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	8.66e-05	0.0203	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	7.96e-05	0.0186	CbGpPWpGaD
Mefenamic acid—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	7.84e-05	0.0183	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.93e-05	0.0162	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	6.51e-05	0.0152	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.1e-05	0.0143	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	5.4e-05	0.0126	CbGpPWpGaD
Mefenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	5.25e-05	0.0123	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	5.15e-05	0.012	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.09e-05	0.0119	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	4.82e-05	0.0113	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.48e-05	0.0105	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.23e-05	0.0099	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.62e-05	0.00847	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.42e-05	0.00801	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	3.22e-05	0.00753	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	3.18e-05	0.00744	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.11e-05	0.00726	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—LIPC—focal segmental glomerulosclerosis	3.09e-05	0.00722	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.01e-05	0.00705	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	2.96e-05	0.00692	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.78e-05	0.0065	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.72e-05	0.00636	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	2.66e-05	0.00623	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	2.66e-05	0.00622	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.66e-05	0.00622	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.5e-05	0.00586	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	2.5e-05	0.00585	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.27e-05	0.0053	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.17e-05	0.00507	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	2.11e-05	0.00495	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	2.11e-05	0.00494	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.09e-05	0.00489	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.04e-05	0.00477	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CTGF—focal segmental glomerulosclerosis	2e-05	0.00467	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.99e-05	0.00466	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	1.99e-05	0.00464	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—LPL—focal segmental glomerulosclerosis	1.88e-05	0.00441	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.84e-05	0.0043	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.84e-05	0.0043	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.83e-05	0.00428	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.79e-05	0.00418	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.68e-05	0.00394	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—LPL—focal segmental glomerulosclerosis	1.65e-05	0.00386	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—AGT—focal segmental glomerulosclerosis	1.61e-05	0.00377	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.61e-05	0.00376	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.54e-05	0.0036	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.53e-05	0.00357	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.49e-05	0.00349	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.41e-05	0.00329	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—LPL—focal segmental glomerulosclerosis	1.38e-05	0.00324	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.37e-05	0.00321	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.34e-05	0.00314	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.31e-05	0.00307	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NOS2—focal segmental glomerulosclerosis	1.29e-05	0.00302	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	1.28e-05	0.003	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.24e-05	0.00289	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—ALB—focal segmental glomerulosclerosis	1.24e-05	0.00289	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.24e-05	0.00289	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.23e-05	0.00288	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.19e-05	0.00279	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.18e-05	0.00277	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AGT—focal segmental glomerulosclerosis	1.18e-05	0.00277	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.16e-05	0.00271	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—LPL—focal segmental glomerulosclerosis	1.11e-05	0.0026	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.1e-05	0.00256	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—SERPINE1—focal segmental glomerulosclerosis	1.09e-05	0.00254	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	1.06e-05	0.00247	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.04e-05	0.00244	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.03e-05	0.00242	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.89e-06	0.00231	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	9.63e-06	0.00225	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.46e-06	0.00221	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—LPL—focal segmental glomerulosclerosis	9.31e-06	0.00218	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.14e-06	0.00214	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	9.1e-06	0.00213	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—ALB—focal segmental glomerulosclerosis	9.08e-06	0.00212	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS2—focal segmental glomerulosclerosis	8.68e-06	0.00203	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.48e-06	0.00198	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.02e-06	0.00188	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AGT—focal segmental glomerulosclerosis	7.96e-06	0.00186	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	7.84e-06	0.00183	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.78e-06	0.00182	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	7.78e-06	0.00182	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.61e-06	0.00178	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.37e-06	0.00172	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—SERPINE1—focal segmental glomerulosclerosis	7.31e-06	0.00171	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.22e-06	0.00169	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	7.18e-06	0.00168	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.9e-06	0.00161	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—TGFB1—focal segmental glomerulosclerosis	6.86e-06	0.0016	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.66e-06	0.00156	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	6.64e-06	0.00155	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.18e-06	0.00145	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.15e-06	0.00144	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ALB—focal segmental glomerulosclerosis	6.11e-06	0.00143	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.97e-06	0.0014	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.88e-06	0.00137	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	5.84e-06	0.00137	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.83e-06	0.00136	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.38e-06	0.00126	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	5.27e-06	0.00123	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.12e-06	0.0012	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.03e-06	0.00118	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.8e-06	0.00112	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.78e-06	0.00112	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.74e-06	0.00111	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.64e-06	0.00109	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—focal segmental glomerulosclerosis	4.61e-06	0.00108	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	4.29e-06	0.001	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.27e-06	0.001	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.09e-06	0.000957	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	4.05e-06	0.000948	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.92e-06	0.000917	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.86e-06	0.000902	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	3.84e-06	0.000898	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	3.77e-06	0.000883	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	3.49e-06	0.000816	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.48e-06	0.000814	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	3.47e-06	0.000811	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.23e-06	0.000756	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	3.22e-06	0.000752	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.14e-06	0.000734	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	3.07e-06	0.000719	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	3e-06	0.000702	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.83e-06	0.000662	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	2.75e-06	0.000644	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	2.66e-06	0.000622	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	2.62e-06	0.000612	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	2.53e-06	0.000591	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	2.24e-06	0.000524	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.13e-06	0.000498	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	2.11e-06	0.000494	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.82e-06	0.000426	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	1.72e-06	0.000402	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	1.59e-06	0.000373	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.4e-06	0.000327	CbGpPWpGaD
